Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017, Article ID 5762301, 12 pages
https://doi.org/10.1155/2017/5762301
Research Article

Delayed Mesoderm and Erythroid Differentiation of Murine Embryonic Stem Cells in the Absence of the Transcriptional Regulator FUBP1

1Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Paul-Ehrlich-Strasse 42-44, 60596 Frankfurt/Main, Germany
2LOEWE Center for Cell and Gene Therapy Frankfurt and Department for Medicine, Hematology/Oncology, Goethe University Hospital Frankfurt/Main, 60590 Frankfurt/Main, Germany
3Institute of Biochemistry II, Goethe University Frankfurt, 60590 Frankfurt/Main, Germany
4German Cancer Consortium (DKTK), 69120 Heidelberg, Germany

Correspondence should be addressed to Martin Zörnig; ed.trufknarf-inu.hsg@ginreoz

Received 21 December 2016; Revised 2 March 2017; Accepted 19 March 2017; Published 15 May 2017

Academic Editor: Zhaohui Ye

Copyright © 2017 Josephine Wesely et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. I. Avigan, B. Strober, and D. Levens, “A far upstream element stimulates c-myc expression in undifferentiated leukemia cells,” The Journal of Biological Chemistry, vol. 265, no. 30, pp. 18538–18545, 1990. View at Google Scholar
  2. M. Y. Jia and Y. J. Wang, “Far upstream element-binding protein 1(FUBP1) expression differs between human colorectal cancer and non-cancerous tissue,” Neoplasma, vol. 61, no. 5, pp. 533–540, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Malz, A. Weber, S. Singer et al., “Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells,” Hepatology, vol. 50, no. 4, pp. 1130–1139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. U. Rabenhorst, R. Beinoraviciute-Kellner, M. L. Brezniceanu et al., “Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth,” Hepatology, vol. 50, no. 4, pp. 1121–1129, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Weber, I. Kristiansen, M. Johannsen et al., “The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer,” BMC Cancer, vol. 8, no. 1, p. 369, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. U. Rabenhorst, F. B. Thalheimer, K. Gerlach et al., “Single-stranded DNA-binding transcriptional regulator FUBP1 is essential for fetal and adult hematopoietic stem cell self-renewal,” Cell Reports, vol. 11, no. 12, pp. 1847–1855, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Zhou, Y. J. Chung, E. R. Parrilla Castellar et al., “Far upstream element binding protein plays a crucial role in embryonic development, hematopoiesis, and stabilizing Myc expression levels,” The American Journal of Pathology, vol. 186, no. 3, pp. 701–715, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Wray, T. Kalkan, and A. G. Smith, “The ground state of pluripotency,” Biochemical Society Transactions, vol. 38, no. 4, pp. 1027–1032, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Martello and A. Smith, “The nature of embryonic stem cells,” Annual Review of Cell and Developmental Biology, vol. 30, no. 1, pp. 647–675, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. A. G. Smith and M. L. Hooper, “Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells,” Developmental Biology, vol. 121, no. 1, pp. 1–9, 1987. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Avior, I. Sagi, and N. Benvenisty, “Pluripotent stem cells in disease modelling and drug discovery,” Nature Reviews. Molecular Cell Biology, vol. 17, no. 3, pp. 170–182, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Li, Y. Kong, M. Zhang, F. Xie, P. Liu, and S. Xu, “Differentiation of pluripotent stem cells for regenerative medicine,” Biochemical and Biophysical Research Communications, vol. 471, no. 1, pp. 1–4, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Picanco-Castro, L. F. Moreira, S. Kashima, and D. T. Covas, “Can pluripotent stem cells be used in cell-based therapy?” Cellular Reprogramming, vol. 16, no. 2, pp. 98–107, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Kingham and R. O. Oreffo, “Embryonic and induced pluripotent stem cells: understanding, creating, and exploiting the nano-niche for regenerative medicine,” ACS Nano, vol. 7, no. 3, pp. 1867–1881, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Klimanskaya, N. Rosenthal, and R. Lanza, “Derive and conquer: sourcing and differentiating stem cells for therapeutic applications,” Nature Reviews. Drug Discovery, vol. 7, no. 2, pp. 131–142, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Wang, X. Luo, and J. Leighton, “Extracellular matrix and integrins in embryonic stem cell differentiation,” Biochemistry Insights, vol. 8, Supplement 2, pp. 15–21, 2015. View at Publisher · View at Google Scholar
  17. E. Garcia-Alegria, S. Menegatti, K. Batta, S. Cuvertino, M. Florkowska, and V. Kouskoff, “Emerging concepts for the in vitro derivation of murine haematopoietic stem and progenitor cells,” FEBS Letters, vol. 590, no. 22, pp. 4116–4125, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Wahlster and G. Q. Daley, “Progress towards generation of human haematopoietic stem cells,” Nature Cell Biology, vol. 18, no. 11, pp. 1111–1117, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Koike, S. Sakaki, Y. Amano, and H. Kurosawa, “Characterization of embryoid bodies of mouse embryonic stem cells formed under various culture conditions and estimation of differentiation status of such bodies,” Journal of Bioscience and Bioengineering, vol. 104, no. 4, pp. 294–299, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Kurosawa, “Methods for inducing embryoid body formation: in vitro differentiation system of embryonic stem cells,” Journal of Bioscience and Bioengineering, vol. 103, no. 5, pp. 389–398, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. C. Poh, J. Chen, Y. Hong, H. Yi, S. Zhang, J. Chen et al., “Generation of organized germ layers from a single mouse embryonic stem cell,” Nature Communications, vol. 5, article 4000, p. 1, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. A. C. Komor, A. H. Badran, and D. R. Liu, “CRISPR-based technologies for the manipulation of eukaryotic genomes,” Cell, vol. 168, no. 1-2, pp. 20–36, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. L. A. Boyer, T. I. Lee, M. F. Cole et al., “Core transcriptional regulatory circuitry in human embryonic stem cells,” Cell, vol. 122, no. 6, pp. 947–956, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Chambers and S. R. Tomlinson, “The transcriptional foundation of pluripotency,” Development, vol. 136, no. 14, pp. 2311–2322, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Hawkins, S. Joy, and T. McKay, “Cell signalling pathways underlying induced pluripotent stem cell reprogramming,” World Journal of Stem Cells, vol. 6, no. 5, pp. 620–628, 2014. View at Publisher · View at Google Scholar
  26. G. Huang, S. Ye, X. Zhou, D. Liu, and Q. L. Ying, “Molecular basis of embryonic stem cell self-renewal: from signaling pathways to pluripotency network,” Cellular and Molecular Life Sciences, vol. 72, no. 9, pp. 1741–1757, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Nakano, H. Kodama, and T. Honjo, “Generation of lymphohematopoietic cells from embryonic stem cells in culture,” Science, vol. 265, no. 5175, pp. 1098–1101, 1994. View at Publisher · View at Google Scholar
  28. J. Zheng, K. Kitajima, E. Sakai et al., “Differential effects of GATA-1 on proliferation and differentiation of erythroid lineage cells,” Blood, vol. 107, no. 2, pp. 520–527, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Hooper, K. Hardy, A. Handyside, S. Hunter, and M. Monk, “HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells,” Nature, vol. 326, no. 6110, pp. 292–295, 1987. View at Publisher · View at Google Scholar
  30. N. E. Sanjana, O. Shalem, and F. Zhang, “Improved vectors and genome-wide libraries for CRISPR screening,” Nature Methods, vol. 11, no. 8, pp. 783-784, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. J. H. Schefe, K. E. Lehmann, I. R. Buschmann, T. Unger, and H. Funke-Kaiser, “Quantitative real-time RT-PCR data analysis: current concepts and the novel “gene expression’s CT difference” formula,” Journal of Molecular Medicine (Berlin), vol. 84, no. 11, pp. 901–910, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Brambrink, R. Foreman, G. G. Welstead et al., “Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells,” Cell Stem Cell, vol. 2, no. 2, pp. 151–159, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Zhao, X. Ji, F. Zhang, L. Li, and L. Ma, “Embryonic stem cell markers,” Molecules, vol. 17, no. 6, pp. 6196–6236, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Lolas, P. D. Valenzuela, R. Tjian, and Z. Liu, “Charting Brachyury-mediated developmental pathways during early mouse embryogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 12, pp. 4478–4483, 2014. View at Google Scholar
  35. A. L. Evans, T. Faial, M. J. Gilchrist et al., “Genomic targets of Brachyury (T) in differentiating mouse embryonic stem cells,” PloS One, vol. 7, no. 3, article e33346, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Zhang and Q. M. Chen, “Far upstream element binding protein 1: a commander of transcription, translation and beyond,” Oncogene, vol. 32, no. 24, pp. 2907–2916, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Faial, A. S. Bernardo, S. Mendjan et al., “Brachyury and SMAD signalling collaboratively orchestrate distinct mesoderm and endoderm gene regulatory networks in differentiating human embryonic stem cells,” Development, vol. 142, no. 12, pp. 2121–2135, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. S. I. Nishikawa, S. Nishikawa, M. Hirashima, N. Matsuyoshi, and H. Kodama, “Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages,” Development, vol. 125, no. 9, pp. 1747–1757, 1998. View at Google Scholar
  39. T. Inoue-Yokoo, K. Tani, and D. Sugiyama, “Mesodermal and hematopoietic differentiation from ES and iPS cells,” Stem Cell Reviews, vol. 9, no. 4, pp. 422–434, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. H. K. Mikkola and S. H. Orkin, “The journey of developing hematopoietic stem cells,” Development, vol. 133, no. 19, pp. 3733–3744, 2006. View at Publisher · View at Google Scholar · View at Scopus